[go: up one dir, main page]

PE20000423A1 - Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene - Google Patents

Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Info

Publication number
PE20000423A1
PE20000423A1 PE1999000296A PE00029699A PE20000423A1 PE 20000423 A1 PE20000423 A1 PE 20000423A1 PE 1999000296 A PE1999000296 A PE 1999000296A PE 00029699 A PE00029699 A PE 00029699A PE 20000423 A1 PE20000423 A1 PE 20000423A1
Authority
PE
Peru
Prior art keywords
cafiles
methylpropionic acid
pharmaceutical composition
composition containing
acid derivative
Prior art date
Application number
PE1999000296A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Harunobu Mukaiyama
Akihito Hirabayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PE20000423A1 publication Critical patent/PE20000423A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN DERIVADO DEL ACIDO 2-METILPROPIONICO DE FORMULA I, DONDE R1 ES H, ALQUILO, ARALQUILO; R2 ES H, ALQUILO, HALOGENO; A ES O, IMINO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I TIENE EFECTOS ESTIMULANTES DE ß3-ADRENOCEPTORES Y PUEDE SER UTIL PARA LA PREVENCION O TRATAMIENTO DE LA OBESIDAD, HIPERGLICEMIA, ENFERMEDADES CAUSADAS POR LA HIPERMOTILIDAD INTESTINAL, POLAQUIURIA, INCONTINENCIA URINARIA, DEPRESION, ENFERMEDDES CAUSADAS POR CALCULOS BILIARES, HIPERMOTILIDAD DEL TRACTO BILIAR
PE1999000296A 1998-04-14 1999-04-12 Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene PE20000423A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14202898 1998-04-14

Publications (1)

Publication Number Publication Date
PE20000423A1 true PE20000423A1 (es) 2000-05-22

Family

ID=15305697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000296A PE20000423A1 (es) 1998-04-14 1999-04-12 Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene

Country Status (19)

Country Link
US (2) US6696489B1 (es)
EP (1) EP1072583B1 (es)
JP (1) JP4212771B2 (es)
KR (1) KR100576131B1 (es)
AR (1) AR015761A1 (es)
AT (1) ATE275126T1 (es)
AU (1) AU768217C (es)
CA (1) CA2328348C (es)
CO (1) CO5021214A1 (es)
DE (1) DE69919860T2 (es)
ES (1) ES2228028T3 (es)
IL (1) IL138994A (es)
MY (1) MY122400A (es)
NO (1) NO20005164L (es)
NZ (1) NZ507486A (es)
PE (1) PE20000423A1 (es)
TW (1) TW581754B (es)
WO (1) WO1999052856A1 (es)
ZA (1) ZA200005589B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4005771B2 (ja) * 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体の結晶多形
EP1559427B1 (en) 2002-11-07 2011-03-09 Astellas Pharma Inc. Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
EP1593666B1 (en) * 2003-02-14 2008-07-02 Kissei Pharmaceutical Co., Ltd. Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
ITMI20061581A1 (it) 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
ES2665467T3 (es) 2010-03-29 2018-04-25 Astellas Pharma Inc. Composición farmacéutica de liberación modificada
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
DE3061334D1 (en) 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
FR2750668B1 (fr) 1996-07-03 1998-11-20 Savard Franck Dispositif de tension et de guidage d'une chaine pour un changement de vitesses de velo
WO1998013333A1 (en) * 1996-09-26 1998-04-02 Kissei Pharmaceutical Co., Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives
ID24062A (id) 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
ES2209226T3 (es) * 1997-12-18 2004-06-16 Kissei Pharmaceutical Co., Ltd. Derivados de acido fenilaminoalquilcarboxilico y composiciones medicamentosas que los contiienen.

Also Published As

Publication number Publication date
MY122400A (en) 2006-04-29
CA2328348C (en) 2009-03-03
AU768217B2 (en) 2003-12-04
US6790865B2 (en) 2004-09-14
AU3166199A (en) 1999-11-01
AR015761A1 (es) 2001-05-16
CA2328348A1 (en) 1999-10-21
EP1072583A4 (en) 2001-12-05
EP1072583A1 (en) 2001-01-31
EP1072583B1 (en) 2004-09-01
JP4212771B2 (ja) 2009-01-21
ZA200005589B (en) 2002-01-11
WO1999052856A1 (en) 1999-10-21
TW581754B (en) 2004-04-01
IL138994A (en) 2004-02-19
US20030166719A1 (en) 2003-09-04
DE69919860D1 (de) 2004-10-07
KR100576131B1 (ko) 2006-05-03
KR20010042683A (ko) 2001-05-25
NZ507486A (en) 2003-03-28
DE69919860T2 (de) 2005-08-25
ES2228028T3 (es) 2005-04-01
IL138994A0 (en) 2001-11-25
AU768217C (en) 2005-04-21
ATE275126T1 (de) 2004-09-15
NO20005164L (no) 2000-12-12
CO5021214A1 (es) 2001-03-27
NO20005164D0 (no) 2000-10-13
US6696489B1 (en) 2004-02-24

Similar Documents

Publication Publication Date Title
AR029600A1 (es) Un derivado del acido fenoxiacetico, una composicion farmaceutica que lo contiene y agente util para la prevencion de enfermedades, uso de un derivado del acido fenoxiacetico para la fabricacion de una composicion farmaceutica para los tratamientos de dichas enfermedades y el procedimiento de fabric
BR0211502A (pt) Derivados de ácido acético de indano e seu uso como agentes farmacêuticos, intermediários, e método de preparação
BR0009864A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto
ES2115096T3 (es) Derivados tetrazolicos de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
EA200300316A1 (ru) Производные глюкопиранозилоксибензилбензола и содержащие их лекарственные композиции
AP2000001860A0 (en) Hypolipidemic benzothiazepine compounds.
BR0010555A (pt) Inibidores de neuraminidases
EP1072592A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
BR0316877A (pt) Derivados de aril-quinazolina/aril-2-amino-fenil metanona que promovem a liberação de hormÈnio da paratireóide
EP1891954A3 (en) Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
EA200200194A1 (ru) Антагонисты хемокинного рецептора и способы их применения
NO20076425L (no) Fremgangsmater for behandling av drug-resistent cancer
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
PE20000423A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
PE20000131A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
CO5550443A2 (es) Derivados de 4-aril-2(1h)-quinazolina, su proceso de preparacion y una composicion farmaceutica que los contiene
CO5390085A1 (es) Metodo para tratar enfermedades o condiciones desmielinizantes
ATE281432T1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
PE20040668A1 (es) Nuevos derivados de piperidina
ES2051954T3 (es) 2-aminotiazoles substituidos.
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed